Federal Health Grants

This funding opportunity supports innovative research projects that aim to improve the use of genomic information in clinical care, particularly for diverse populations, with a focus on health outcomes and addressing disparities.

This funding opportunity supports researchers in developing practical medical solutions that improve health outcomes for military service members, veterans, and their families by translating scientific discoveries into clinical applications.

The United States Agency for International Development in Democratic Republic of Congo (USAID/DRC) is seeking applications for a Fixed Amount Award (FAA) Cooperative Agreement from qualified entities to implement the USAID Espoir 2030 in Haut Katanga. Eligibility for this award is restricted to local non-governmental entities as defined in ADS 303.6. USAID intends to make an award to the applicant who best meets the objectives of this funding opportunity based on the merit review criteria described in this NOFO subject to a risk assessment. Eligible parties interested in submitting an application are encouraged to read this NOFO thoroughly to understand the type of program sought, application submission requirements and selection process. USAID/DRC envisions that the USAID Espoir 2030 Haut-Katanga award will be five-year long activities that will focus on service delivery in three (3) zones outside Lubumbashi. The activity will collaborate with existing (EpiC, IHP, Chemonics Francophone Task Order) and other USAID and development partners implementing HIV programming. The number of health zones supported in the province can change depending on PEPFAR and the GDRC orientations. The service delivery model intends that each activity in a specific province will include all aspects of HIV epidemic control, Orphans and Vulnerable Children (OVC) and key populations (KPs) programming, to ensure smooth transition of the existing key populations program (EpiC). More details are available from full Notice of Funding Opportunity (NOFO) as posted with this synopsis. The French Version of this funding opportunity will be added to the package by March 26, 2024

This grant provides funding exclusively to Cincinnati Children’s Hospital Medical Center to develop a Data Coordinating Center for a large-scale research initiative focused on understanding congenital heart disease through genomic studies and diverse participant engagement.

This funding opportunity provides financial support to local governments and tribal organizations to implement community-based programs that help individuals experiencing homelessness and mental health or substance use challenges access treatment and housing stability.

This funding opportunity is exclusively for the University of North Carolina at Chapel Hill to continue a major study tracking the health and life experiences of individuals from adolescence to midlife, focusing on factors related to Alzheimer's disease and related dementias.

This funding opportunity provides financial support to small rural hospitals and health clinics to help them improve their healthcare services and transition to a value-based care system for better patient outcomes.

This notice of funding opportuntity (NOFO) encourages applications for investigator-initiated multi site clinical trials (e.g., efficacy, effectiveness, or pragmatic trials) to study the effects of complementary and integrative health approaches with physical and/or psychological therapeutic inputs (often called mind and body interventions), and/or multicomponent interventions that include physical, psychological, and/or nutritional approaches in NCCIH- designated areas of high research priority. Clinical Coordinating Centers (CCC) should develop and implement the proposed fully powered multi-site clinical trial (Phase III and beyond). The objective of a CCC application is to present the scientific rationale and a comprehensive scientific and operational plan for the clinical trial. CCCapplications are expected to describe plans for project management, participant recruitment and retention strategies, performance milestones, scientific conduct, and dissemination of results. CCC applications submitted under this NOFO will utilize a two-phase, milestone-driven cooperative agreement (UG3/UH3) funding mechanism. In addition, an accompanying Data Coordinating Center (DCC) application (U24), submitted under PAR-24-087 proposing a data analysis and data management plan for the clinical project is required. Both a CCC application and a corresponding DCC application need to be submitted simultaneously for consideration by NCCIH. For additional information about the mission, strategic vision, and research priorities of NCCIH, applicants are encouraged to consult the NCCIH website: (https://nccih.nih.gov/about/plans). Applicants are encouraged to contact the appropriate Scientific/Research contact for the area of science for which they are planning to develop an application prior to submitting to this NOFO.

This funding opportunity provides financial support to early-career researchers in the fields of arthritis, musculoskeletal, and skin diseases, helping them conduct small-scale studies as they transition to independent investigator roles.

The "Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities" grant aims to fund research projects that explore and address the effects of structural racism and discrimination on the health of minority and disadvantaged groups, with the goal of improving health outcomes and promoting health equity.

This funding opportunity provides financial support to early-career researchers in the dental and craniofacial fields to conduct pilot studies that will help them secure larger research grants in the future.

This grant provides financial support for arts projects that enhance the well-being of military service members, veterans, and their families through creative engagement and art-making experiences.

This funding opportunity supports innovative researchers exploring groundbreaking ideas in tuberous sclerosis complex, aiming to generate preliminary data for future studies that benefit service members, veterans, and the public.

This funding opportunity is designed for U.S.-based small businesses to develop FDA-regulated treatments and diagnostic tools for individuals struggling with opioid and stimulant use disorders.

This funding opportunity provides substantial financial support to nonprofit organizations and government entities for developing a national center that enhances training and technical assistance for peer-run behavioral health services, focusing on improving mental health care for individuals with serious mental illness.

(Reissue of PAR-18-486) The purpose of the NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01) is to diversify the pool of independent neuroscience research investigators by providing junior faculty with research cost support, protected research time and career stage appropriate professional development mentorship in neuroscience research. Individuals from backgrounds underrepresented in biomedical research are eligible for support under this award if they have doctoral research degrees (Ph.D. or equivalent) and are in the first 3 years of a faculty tenure track or equivalent position at the time of application. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing to serve as the lead investigator of an independent clinical trial, a clinical trial feasibility study, or a separate ancillary study to an existing trial, as part of their research and career development. NINDS will only accept applications to this FOA that propose human mechanistic trials/studies that meet NIH's definition of a clinical trial and that fall within the NINDS research priorities. Applicants are strongly advised to consult with NINDS program staff prior to submitting an application with human subjects to determine the appropriate funding opportunity.

The purpose of this Notice of Funding Opportunity Announcement (NOFO) is to solicit applications for the Coordinating Center (CC) of the ML/AI Tools to Advance Genomic Translational Research (MAGen) Consortium. In collaboration with the MAGen Sites funded by the companion NOFO (RFA-HG-24-004) the CC will explore the feasibility of developing Machine Learning (ML) and Artificial Intelligence (AI) tools that can enhance the accuracy and precision of predicting how individuals with pathogenic genetic variants manifest disease. The CC will be responsible for implementing approaches to bring diverse teams together to enable synergistic and collaborative team science across the Consortium. Specifically, the CC will be responsible for technical, scientific, and administrative coordination activities to support the Consortium research activities including development of consortium wide plans, coordinated ELSI-informed ML/AI tool development and cross validation, and dissemination of the developed resources.

Substance use needs to be better incorporated into interventions for the engagement and retention of sexual minority persons in prevention and care with attention to emergent interventions such as long-acting PrEP. Social determinants of health associated with HIV and problematic substance use such as homelessness and criminal justice involvement also demonstrate disproportionate impact among sexual and gender minorities and need attention. Changing self-definition of sexual minority status has implications for outreach and provider stigma and needs to be better integrated into interventions. This initiative will address these gap areas and support epidemiologic, intervention, and implementation research that incorporates attention to HIV as a syndemic including comorbidities such as STIs, HCV, and psychiatric disorder.

This funding opportunity provides financial support to a variety of organizations, including local governments and nonprofits, to strengthen the capacity of regional authorities in Tanzania to effectively manage and deliver comprehensive HIV and tuberculosis prevention, care, and treatment services.

This funding opportunity supports researchers in analyzing and integrating existing data to better understand cancer risks and outcomes, ultimately advancing cancer research and treatment strategies.